A next-generation drug causes dramatic weight loss. Here’s how much.

CTV News CTV News

Eli Lilly said on Thursday its experimental obesity drug helped patients lose more than 28 per cent of their weight over a year and a half in a key trial that allows the company to seek regulatory approval and potentially launch the next-generation drug next year.

Read full article at CTV News →